抗血小板治疗在血管内治疗缺血性脑血管病中的应用

血管内治疗能显著降低缺血性脑血管病的致残、病死及卒中复发率。随着神经介入技术 和材料以及患者筛选策略的进步，缺血性卒中患者应用血管内治疗也日益增加。抗血小板治疗作为 缺血性卒中预防和治疗的重要手段，是血管内治疗中的重要一环，阿司匹林、氯吡格雷等是基石性 抗血小板药物，但具体的用药方案尚不统一。本文回顾和总结了国内外指南针对缺血性脑血管病行 血管内治疗患者的抗血小板策略建议，以及重要血管内治疗研究中采用的抗血小板治疗方案，以期 为神经介入医师行血管内治疗时抗血小板药物的应用提供参考。

Antiplatelet Therapy in Endovascular Treatment for Ischemic Cerebrovascular Disease

Endovascular treatment (EVT) can significantly reduce the morbidity, mortality
and recurrence of ischemic cerebrovascular disease. With the development of EVT technology,
materials, and patients screening strategy, EVT is increasely used in patients with ischemic stroke.
As an important prevention and treatment regimen of ischemic stroke, antiplatelet therapy is an
important part of EVT. Aspirin and clopidogrel are cornerstone antiplatelet agents, however, the
specific antiplatelet regimen has not yet been unified. This article reviewed the recommendations of
several guidelines for antiplatelet strategies for EVT patients, as well as the antiplatelet regimen in
important EVT studies, to provide reference for neuointerventionists.